News and Issues 1 min read FDA Grants Standalone Approval for J&J’s Ketamine-Based Nasal Spray for Severe Depression vero January 23, 2025
News and Issues 1 min read BREAKTHROUGH! SPRAVATO® Approved as First Solo Medication for Treatment-Resistant Depression vero January 23, 2025
News and Issues 1 min read FDA Approves SPRAVATO® as Breakthrough Monotherapy for Treatment-Resistant Depression vero January 23, 2025
News and Issues 1 min read FDA Approves SPRAVATO® as a Breakthrough Monotherapy for Treatment-Resistant Depression vero January 23, 2025
News and Issues 1 min read Breakthrough FDA Approval: SPRAVATO® Marks a New Era in Treating Treatment-Resistant Depression vero January 23, 2025
